EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Aplastic Anemia in Focus: Insights into Diagnosis and Emerging Therapies

Anurag Singh, Pallavi Srivastava, Alka Singh, Ankita Singh, Rahul Kumar Gupta

Annals of African Medicine · 2026-09 · 25 (5) · 1025-1032

DOI: 10.4103/aam.aam_196_25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of African Medicine, online erschienen am 05.11.2025. Verfasst von Anurag Singh und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Anemia, Aplastic, Hematopoietic Stem Cell Transplantation. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aplastic anaemia (AA) is a rare and life-threatening condition characterized by the failure of bone marrow to produce adequate blood cells. An autoimmune reaction of T lymphocytes against hematopoietic stem cells (HSCs) is the primary etiology. However, less commonly, a congenital deficiency or an acquired injury to these cells can also suppress their division and differentiation. Guidelines for practitioners to manage AA are frequently ambiguous. Close follow-up and monitoring are essential in managing patients with AA, necessitating physicians to comprehend the etiopathology of the disease. Clinical hematologists frequently provide specific treatments, but the physician must stay informed and cognisant of the latest management guidelines for the condition. In the management of AA, both specific and auxiliary modalities hold considerable significance. The databases that were used for the literature study were PubMed/Medline, Embase, Scopus, and Web of Science. Search terms included “Aplastic anaemia.” Articles from after 2006 that were relevant to diagnosis and management instructions were the only ones that were used. The things that were not allowed were scholarly posters, abstracts, and studies with nonhuman subjects. In recent years, there has been a substantial evolution in the concepts related to treating AA. This is attributable to improved outcomes in both familial and nonfamilial donor HSC transplants, alongside current advancements in immunosuppressive and gene therapy. This review article presents the current scientific insights by emphasizing the diagnostic protocols and developments in therapies, including the impacts of gene therapy, immunosuppressive agents, and HSC transplantation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticHematopoietic Stem Cell TransplantationHumansImmunosuppressive Agents

Stichwörter der Autor:innen

Anémie aplasiqueAplastic anemiagreffe de cellules souches hématopoïétiqueshematopoietic stem cell transplantationimmunosuppressive therapiesneutropenianeutropéniethrombocytopeniathrombocytopénietraitements immunosuppresseurs

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pathology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

Zitieren

APA

Singh, A., Srivastava, P., Singh, A., Singh, A., & Gupta, R. K. (2026). Aplastic Anemia in Focus: Insights into Diagnosis and Emerging Therapies. Annals of African Medicine, 25(5), 1025-1032. https://doi.org/10.4103/aam.aam_196_25

Vancouver

Singh A, Srivastava P, Singh A, Singh A, Gupta RK. Aplastic Anemia in Focus: Insights into Diagnosis and Emerging Therapies. Annals of African Medicine. 2026;25(5):1025-1032. doi:10.4103/aam.aam_196_25

BibTeX
@article{Singh2026,
  author = {Singh, Anurag and Srivastava, Pallavi and Singh, Alka and Singh, Ankita and Gupta, Rahul Kumar},
  title = {Aplastic Anemia in Focus: Insights into Diagnosis and Emerging Therapies},
  journal = {Annals of African Medicine},
  year = {2026},
  volume = {25},
  number = {5},
  pages = {1025--1032},
  doi = {10.4103/aam.aam_196_25}
}
Kostenlos starten →